|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||50.95 - 52.04|
|52 Week Range||40.56 - 63.04|
|PE Ratio (TTM)||14.79|
|Earnings Date||May 2, 2018 - May 7, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||56.69|
MEDNAX, Inc. , will host an investor conference call and webcast on Monday, May 7, 2018 at 11:00 a.m. ET, to discuss results from operations for the three months ended March 31, 2018.
On a positive note, the broader healthcare looks delighted with the massive tax cuts. Also, the scenario within the Medical Device space seems equally bright.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting MD. Over the last one-month, outflows of investor capital in ETFs holding MD totaled $1.39 billion.
MedData, Inc., a MEDNAX company and a leading provider of patient-facing financial services for hospitals and health systems, today announced the debut of its comprehensive patient financial platform, MedData OneTouch.
MEDNAX, Inc. , the national health solutions partner specializing in anesthesiology, neonatology, maternal-fetal medicine, other pediatric services, radiology and management services, is pleased to announce that in partnership with Memorial Regional Hospital, it has achieved national accreditation from the Adult Congenital Heart Association for its Adult Congenital Heart Program.
Southeast Anesthesiology Consultants has responded to Atrium Health's countersuit.
Atrium Health has fired the latest legal salvo in an ongoing contract dispute tied to its anesthesia services.
Ensign Group's (ENSG) inclination toward inorganic growth leads to numerous acquisitions, significantly favoring the company's top line.
MEDNAX, Inc. , today announced the acquisition of Children’s Urology Associates, P.A., a private pediatric urology practice based in Miami.
Stock Monitor: American Shared Hospital Services Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 29, 2018 / Active-Investors.com has just released a free research report on MEDNAX, Inc. (NYSE: ...
Atrium Health says it is committed to its recently contracted anesthesia provider — despite a pending lawsuit.
MEDNAX, Inc. (NYSE: MD ) has continued to pursue acquisitions to grow its radiology business segment, making the company a potential private equity target. The company's takeout value appears to be reflected ...
MEDNAX, Inc. , today announced the acquisition of Cool Springs Interventional, LLC based in Franklin, Tenn. The practice was established in 2008 and provides outpatient interventional services.
MEDNAX, Inc. , today announced the acquisition of Children’s Eye Care, LLC, a private pediatric ophthalmology practice based in Kirkland, Wash.
Investment researcher Mark Roberts has made many successful short-sale recommendations over the years, but so far, Mednax ain’t one of them. On March 4, his Off Wall Street Consulting Group put a Sell on the shares of Mednax, which buys medical practices and strikes deals with hospitals for its doctors’ services. Mednax stock had risen 20% since mid-November, to $55, following the disclosure of a 7% holding by Elliott Associates, Paul Singer’s activist firm, which said it hoped to talk with the practice-management company about a possible sale.
American Renal Associates Holdings (ARA) is the largest dialysis services provider in the United States with an exclusive focus on joint venture partnerships with physicians. Of the three analysts covering American Renal Associate Holdings in March 2018, two analysts have given the stock a “strong buy” rating and one analyst has given it a “buy” rating. Of the four analysts covering Civitas Solutions (CIVI) in March 2018, two analysts have given the stock a “strong buy” rating, and two analysts have given it a “buy” rating.
ResMed (RMD) consistently invests and expands globally in high-growth markets like China, South Korea, India, Brazil and across the Eastern Europe belt.